WST - Insider Activity Spotlight: Silji Abraham Acquires In West Pharmaceutical Servs Stock Options | Benzinga
A substantial acquisition of company stock options by Silji Abraham, SVP at West Pharmaceutical Servs (NYSE:WST) was reported on February 22, based on a new SEC filing.
What Happened: Disclosed in a Form 4 filing on Thursday with the U.S. Securities and Exchange Commission, Abraham, SVP at West Pharmaceutical Servs, made a strategic derivative acquisition. This involved acquiring stock options for 2,968 shares of WST, providing the right to buy the company's stock at an exercise price of $350.18 per share.
During Friday's morning session, West Pharmaceutical Servs shares down by 0.0%, currently priced at $359.9. Considering the current price, Abraham's 2,968 shares have a total value of $28,848.
Unveiling the Story Behind West Pharmaceutical Servs
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Key Indicators: West Pharmaceutical Servs's Financial Health
Revenue Growth: West Pharmaceutical Servs's remarkable performance in 3 months is ...